Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Genentech
Genentech
BioNTech, Roche's experimental pancreatic cancer treatment wins Nature plaudit
Yahoo/Reuters
Thu, 05/11/23 - 10:08 am
BioNTech
Roche
Genentech
pancreatic cancer
MRNA
Nature
vaccines
FDA Accepts Application for Genentech’s Vabysmo for the Treatment of Retinal Vein Occlusion (RVO)
BioSpace
Tue, 05/9/23 - 12:27 pm
Roche
Genentech
FDA
Vabysmo
macular edema
retinal vein occlusion
Drugmakers take sides in Amgen, Regeneron fight over antibody patents
BioPharma Dive
Mon, 04/24/23 - 10:17 am
Amgen
Regeneron Pharmaceuticals
Sanofi
Supreme Court
patents
Pfizer
Bayer
Roche
Genentech
AstraZeneca
JNJ
Genentech opens up eye patients’ world with Vabysmo
Medical Marketing and Media
Thu, 04/20/23 - 11:40 pm
Genentech
Vabysmo
wet age-related macular degeneration
DTC ads
FDA Green Lights Roche's Polivy in First-Line DLBCL
BioSpace
Thu, 04/20/23 - 10:45 am
Roche
Genentech
Polivy
diffuse large B-cell lymphoma
FDA
Genentech reveals positive results from cancer combo therapy trial
Clinical Trials Arena
Mon, 04/17/23 - 11:24 am
Genentech
Tecentriq
Avastin
liver cancer
hepatocellular carcinoma
Top biotech licensing deals of Q1 2023
BioSpace
Thu, 03/30/23 - 11:03 am
biotech
licensing
Moderna Therapeutics
CytomX
Voyager Therapeutics
Neurocrine Biosciences
Kronos Bio
Genentech
Karuna Therapeutics
Goldfinch Bio
Genentech turns out lights at first commercial biologics plant, laying off 265 staffers
Fierce Pharma
Thu, 03/23/23 - 09:10 pm
Genentech
Roche
biologics
San Francisco
California
layoffs
At EpiBiologics, a pair of Genentech alumni wants to make next-gen protein degraders
BioPharma Dive
Wed, 03/22/23 - 10:07 am
Genentech
EpiBiologics
protein degradation
FDA advisers question efficacy of Roche’s Polivy in first line LBCL
BioSpace
Wed, 03/8/23 - 11:30 am
Roche
Genentech
Polivy
LBCL
large B-cell lymphoma
Roche sues Biogen over royalties related to multiple sclerosis drug Tysabri
Fierce Pharma
Wed, 03/1/23 - 07:08 pm
Roche
Genentech
patents
MS
multiple sclerosis
legal
Tysabri
Genentech's California biologics facility will support launches in cancer, neuroscience and more: exec
Fierce Pharma
Tue, 02/21/23 - 04:46 pm
Genentech
California
Roche
biologics
drug manufacturing
Genentech to start construction on a new manufacturing facility in California
Endpoints
Sun, 02/12/23 - 07:40 pm
Genentech
Roche
drug manufacturing
California
Roche offers up to $554M in biobucks to in-need Kronos for small-molecule discovery pact
Fierce Biotech
Mon, 01/9/23 - 10:39 am
Kronos Bio
biobucks
AML
Roche
Genentech
small molecule drugs
drug discovery
Roche further taps drug discovery spinout's Nimble tech in $1.1B biobucks deal
Fierce Biotech
Fri, 01/6/23 - 09:33 am
Roche
Genentech
Nimble Therapeutics
biobucks
drug discovery
Genentech makes a flurry of marketing leadership hires
Medical Marketing and Media
Thu, 01/5/23 - 10:07 am
Genentech
marketing
digital marketing
Roche Withdraws Tecentric for Bladder Cancer Indication
BioSpace
Tue, 11/29/22 - 11:06 am
Roche
Genentech
bladder cancer
metastatic bladder cancer
Tecentriq
Genentech starts phase 2 trial to optimize delivery of eye disease cell therapy
Fierce Pharma
Mon, 11/28/22 - 07:41 pm
Genentech
geographic atrophy
clinical trials
OpRegen
cell therapy
Best Places to Work in Biopharma 2023 Report Reveals Most Sought-After Employers
BioSpace
Mon, 11/14/22 - 10:59 am
biotech
biopharma
employers
corporate culture
Moderna Therapeutics
Genentech
Pfizer
Amgen
AbbVie
Roche’s Ocrevus Shines in Relapsing-Remitting MS, Safety Studies
BioSpace
Thu, 11/3/22 - 07:28 pm
Genentech
Roche
Ocrevus
MS
Relapsing Remitting Multiple Sclerosis
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »